Veery Capital, LLC

Position in JNJ — Johnson & Johnson

CIK 1844375 Wilmington, DE

Position in JNJ

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$429,463

+$98,003 QoQ

Shares Held

1,691

+24.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.06%

of 13F equity value

Holder Rank

#3,841

of 4,664 holders

Holding Since

Jun 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Veery Capital, LLC holds $1,998,644 across 6 Drug Manufacturers - General names. JNJ ranks #1 (21.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	1,691	$429,463
2	LLY	ELI LILLY & Co	308	$369,424
3	MRK	Merck & Co., Inc.	2,664	$342,324
4	AZN	Astrazeneca PLC	1,787	$338,850
5	GILD	Gilead Sciences, Inc.	2,330	$294,372
6	ABBV	AbbVie Inc.	891	$224,211

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$429,463	1,691	+24.7%	Shares	Sole	2026-07-09
2026-03-31	$331,460	1,356	-6.1%	Shares	Sole	2026-04-09
2025-12-31	$298,835	1,444	+9.1%	Shares	Sole	2026-01-27
2025-09-30	$245,310	1,323	-0.7%	Shares	Sole	2025-10-15
2025-06-30	$203,463	1,332	-8.4%	Shares	Sole	2025-07-07
2025-03-31	$241,131	1,454	+17.7%	Shares	Sole	2025-04-08
2024-09-30	$200,144	1,235	-43.9%	Shares	Sole	2024-11-06
2024-06-30	$321,844	2,202	-3.6%	Shares	Sole	2024-07-18
2024-03-31	$361,464	2,285	+1.9%	Shares	Sole	2024-04-19
2023-12-31	$351,567	2,243	-6.3%	Shares	Sole	2024-01-10
2023-09-30	$372,865	2,394	+2.3%	Shares	Sole	2023-10-13
2023-06-30	$387,482	2,341	+7.1%	Shares	Sole	2023-07-13
2023-03-31	$338,675	2,185	-0.1%	Shares	Sole	2023-04-13
2022-12-31	$386,333	2,187	-30.6%	Shares	Sole	2023-01-17
2022-09-30	$514,584	3,150	-1.1%	Shares	Sole	2022-10-12
2022-06-30	$565,369	3,185	—	Shares	Sole	2022-07-18
No filing history on record for this holder in this stock.